Literature DB >> 32056187

Radiotherapy for Thoracic Esophageal Squamous Cell Carcinoma.

Wendy W L Chan1, Ka On Lam2, Dora L W Kwong2.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is an aggressive disease. Many patients have locally advanced disease or already have distant metastasis at presentation. Radiotherapy plays an important role in the treatment of esophageal squamous cell carcinoma. Neoadjuvant chemoradiotherapy improves the survival and surgical outcome compared to surgery alone. Definitive radiotherapy (RT) with or without chemotherapy is used in patients who decline surgery or are medically inoperable. Palliative radiotherapy using external beam radiotherapy or intraluminal brachytherapy is effective for dysphagia and pain control.d.

Entities:  

Keywords:  Brachytherapy; Dysphagia; Esophageal cancer; Radiotherapy

Mesh:

Substances:

Year:  2020        PMID: 32056187     DOI: 10.1007/978-1-0716-0377-2_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs.

Authors:  Xiaoqing Li; Shitao Zou; Liangsu Zhou; Aidi Gao; Jing Xu; Chao He; Jundong Zhou; Shuhua Wu; Yihong Chen
Journal:  Cancer Med       Date:  2022-04-14       Impact factor: 4.711

2.  The Protective Mechanism of Afuresertib against Esophageal Cancer.

Authors:  Bo Min; Yan Wang; Feng Liang; Cheng-Xiang Wang; Fan Wang; Zhi Yang
Journal:  Dis Markers       Date:  2022-07-14       Impact factor: 3.464

3.  Characterization of plasma exosomal microRNAs in responding to radiotherapy of human esophageal squamous cell carcinoma.

Authors:  Nan Miao; Wenjie Cai; Sijia Ding; Yajuan Liu; Wanhua Chen; Tao Sun
Journal:  Mol Med Rep       Date:  2022-07-27       Impact factor: 3.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.